La ingesta de boro trata y previene la deficiencia de boro.
La clasificación de la eficacia para este producto es la siguiente: Probablemente eficaz para. 235000019804 chlorophyll Nutrition 0.Natural Medicines Comprehensive Database (La Base Exhaustiva de Datos de Medicamentos Naturales) clasifica la eficacia, basada en evidencia científica, de acuerdo a la siguiente escala: Eficaz, Probablemente Eficaz, Posiblemente Eficaz, Posiblemente Ineficaz, Probablemente Ineficaz, Ineficaz, e Insuficiente Evidencia para Hacer una Determinación.235000010469 Glycine max Nutrition 0.000 claims abstract description 23.150000003626 triacylglycerols Chemical class 0.000 claims abstract description 25.235000005824 corn Nutrition 0.000 claims abstract description 49.235000005822 corn Nutrition 0.000 claims abstract description 49.235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 51.241000497271 Chlorella variabilis Species 0.000 claims abstract description 80.239000000843 powder Substances 0.000 claims abstract description 96.235000013312 flour Nutrition 0.000 claims abstract description 323.
239000002028 Biomass Substances 0.000 claims abstract description 621. 241000195493 Cryptophyta Species 0.000 title claims description 425. 239000000203 mixture Substances 0.000 title claims abstract description 280. Application granted granted Critical Publication of ES2749850T3 publication Critical patent/ES2749850T3/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority to US16927109P priority Critical Priority to US17316609P priority Priority to US24607009P priority Priority to PCT/US2009/060692 priority patent/WO2010045368A2/en Priority to US12/684,886 priority patent/US20100297296A1/en Priority to US12/684,888 priority patent/US20100297325A1/en Priority to US12/684,891 priority patent/US20100297323A1/en Priority to US12/684,884 priority patent/US20100303989A1/en Priority to US12/684,894 priority patent/US20100303957A1/en Priority to US12/684,892 priority patent/US20100303961A1/en Priority to US12/684,887 priority patent/US20100297331A1/en Priority to US12/684,885 priority patent/US20100297295A1/en Priority to US12/684,893 priority patent/US20100303990A1/en Priority to US12/684,889 priority patent/US20100297292A1/en Priority to US29925010P priority Priority to PCT/US2010/031088 priority patent/WO2010120923A1/en Application filed by Corbion Biotech Inc filed Critical Corbion Biotech Inc First worldwide family litigation filed litigation Critical (T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Original Assignee Corbion Biotech Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Geoffrey Brooks Scott Franklin Jeff Avila Stephen M Decker Enrique Baliu Walter Rakitsky John Piechocki Dana Zdanis Lesile M Norris Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number ES10765119T Other languages Spanish ( es)
0 kommentar(er)
